Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials

Update Il y a 4 ans
Reference: NCT00239356

Woman and Man

Extract

The purpose of this study is to provide aripiprazole to schizophrenic outpatients and Community Treated Patients who are currently receiving aripiprazole therapy on another BMS sponsored clinical trial.


Inclusion criteria

  • Schizophrenia


Links